INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2011

Higher estimated enterolactone and enterodiol levels were associated with significantly lower overall mortality in postmenopausal breast cancer patients.

A follow-up study of 2653 postmenopausal breast cancer patients evaluated estimated enterolignans, lignan-rich foods, and dietary fibre in relation to survival over a median follow-up of 6.4 years, during which 321 women died (235 with breast cancer). High estimated enterolactone and enterodiol levels were associated with significantly lower overall mortality (highest quintile HR=0.60, 95% CI=0.40-0.89, PTrend=0.02 and HR=0.63, 95% CI=0.42-0.95, PTrend=0.02, respectively). Fibre intake was also linked to significantly lower overall mortality. When stratified by median fibre intake, associations with estimated enterolignans remained evident at low but not high fibre intake, with no effect modification by oestrogen receptor status or menopausal hormone therapy.

Shows an association, not proof of cause and effect.

Study type
Prospective cohort follow-up study
Who was studied
2653 postmenopausal breast cancer patients diagnosed between 2001 and 2005
What was measured
Overall survival and breast cancer-specific survival

THE PAPER

Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer.

Buck K, Zaineddin AK, Vrieling A, Heinz J, Linseisen J, Flesch-Janys D, Chang-Claude J. Br J Cancer, 2011.

PubMed 21915130 ↗DOI 10.1038/bjc.2011.374 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.